MyMyelomaTeam

Relapsing at 7 months after a transplant is considered an early relapse, and while it's not the most common timing, it does happen. Research shows that about 16% of people with myeloma relapse within one year of completing first-line therapy.

Early relapse can occur for a few reasons, including:

- Not responding fully to Show Full Answer

Relapsing at 7 months after a transplant is considered an early relapse, and while it's not the most common timing, it does happen. Research shows that about 16% of people with myeloma relapse within one year of completing first-line therapy.

Early relapse can occur for a few reasons, including:

- Not responding fully to initial therapy
- Having high-risk disease features
- Relapsing during maintenance therapy The sooner a relapse happens after treatment, the more urgently a new treatment plan is needed. An oncologist will review treatment history, overall health, and the degree of relapse before recommending next steps.

The good news is that there are second-line treatment options available. Sometimes medications that worked before can be effective again, and there are also newer treatment combinations to explore.

It's really important to have an open conversation with the hematologist-oncologist about what options make the most sense given the specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Myeloma Relapse Rates and 9 Treatment Options for Relapses

What Is the Life Expectancy With Relapsed/Refractory Myeloma?